Feline immunodeficiency virus neuropathogenesis: From cats to calcium

Journal of Neuroimmune Pharmacology

Volumn 2, Issue 2, 2007, Pages 154-170

  Meeker, Rick B ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

AIDS; Astrocytes; Dementia; Human immunodeficiency virus; Microglia; Neurons

Indexed keywords

CALCIUM;

ANIMAL; CAT; CAT DISEASE; CENTRAL NERVOUS SYSTEM INFECTION; COMPARATIVE STUDY; FELINE IMMUNODEFICIENCY VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; METABOLISM; NERVE CELL; PATHOLOGY; REVIEW;

ANIMALS; CALCIUM; CATS; CENTRAL NERVOUS SYSTEM VIRAL DISEASES; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; HIV INFECTIONS; HUMANS; IMMUNODEFICIENCY VIRUS, FELINE; NEURONS;

EID: 34247542530     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-006-9045-z     Document Type: Review

References (164)

1. Abramo F, Bo S, Canese MO, Poli A (1995) Regional distribution of lesions in the central nervous system of cats infected with feline immunodeficiency virus. AIDS Res Hum Retrovir 11:1247-1253
2. Ackley CD, Yamamoto JK, Levy N, Pedersen NC, Cooper MD (1990) Immunologie abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus. J Virol 64:5652-5655
3. Allison RW, Hoover EA (2003a) Covert vertical transmission of feline immunodeficiency virus, AIDS Res Hum Retrovir 19:421-434
4. Allison RW, Hoover EA (2003b) Feline immunodeficiency virus is concentrated in milk early in lactation. AIDS Res Hum Retrovir 19:245-253
5. Anthony IC, Ramage SN, Carnie FW, Simmonds P, Bell JE (2005) Influence of HAART on HIV-related CNS disease and neuro-inflammation. J Neuropathol Exp Neurol 64:529-536
6. Arai M, Earl DD, Yamamoto JK (2002) Is AZT/3TC therapy effective against FIV infection or immunopathogenesis? Vet Immunol Immunopathol 85:189-204
7. Barr MC, Billaud JN, Selway DR, Huitron-Resendiz S, Osborn KG, Henriksen SJ, Phillips TR (2000) Effects of multiple acute morphine exposures on feline immunodeficiency virus disease progression. J Infect Dis 182:725-732
8. Bare MC, Huitron-Resendiz S, Sanchez-Alavez M, Henriksen SJ, Phillips TR (2003) Escalating morphine exposures followed by withdrawal in feline immunodeficiency virus-infected cats: a model for HIV infection in chronic opiate abusers, Drug Alcohol Depend 72:141-149
9. Beebe AM, Dua N, Faith TG, Moore PF, Pedersen NC, Dandekar S (1994) Primary stage of feline immunodeficiency virus infection: viral dissemination and cellular targets. J Virol 68:3080-3091
10. Billaud JN, Selway D, Yu N, Phillips TR (2000) Replication rate of feline immunodeficiency virus in astrocytes is envelope dependent: implications for glutamate uptake. Virology 266:180-188
11. Bisset LR, Lutz H, Boni J, Hofmann-Lehmann R, Luthy R, Schupbach J (2002) Combined effect of zidovudine (ZDV), lamivudine (3TC) and abacavir (ABC) antiretroviral therapy in suppressing in vitro FIV replication, Antiviral Res 53:35-45
12. Boche D, Hurtrel M, Gray F, Claessens-Maire MA, Ganiere JP, Montagnier, Hurtrel B (1996) Virus load and neuropathology in the FIV model. J Neurovirology 2:377-387
13. Bragg D, Childers T, Tompkins M, Tompkins W, Meeker R (2002a) Infection of the choroid plexus by feline immunodeficiency virus. J Neurovirology 8:211-224
14. Bragg D, Hudson L, Liang Y, Tompkins M, Fernandes A, Meeker R (2002b) Choroid plexus macrophages proliferate and release toxic factors in response to feline immunodeficiency virus. J Neurovirology 8:225-239
15. Bragg DC, Boles JC, Meeker RB (2002c) Destabilization of neuronal calcium homeostasis by factors secreted from choroid plexus macrophage cultures in response to feline immunodeficiency virus. Neurobiol Dis 9:173-186
16. Bragg DC, Meeker RB, Duff BA, English RV, Tompkins MB (1999) Neurotoxicity of FIV and FIV envelope protein in feline cortical cultures. Brain Res 816:431-437
17. Brinkmann R, Schwinn A, Muller J, Stahl-Hennig C, Coulibaly C, Hunsmann G, Czub S, Rethwilm A, Dorries R, Ter MV (1993) In vitro and in vivo infection of rhesus monkey microglial cells by simian immunodeficiency virus, Virology 195:561-568
18. Brown WC, Bissey L, Logan KS, Pedersen NC, Elder JH, Collisson EW (1991) Feline immunodeficiency virus infects both CD4+ and CD8+ T lymphocytes. J Virol 65:3359-3364
19. Brunner D, Pedersen NC (1989) Infection of peritoneal macrophages in vitro and in vivo with feline immunodeficiency virus. J Virol 63:5483-5488
20. Bucci JG, English RV, Jordan HL, Childers TA, Tompkins MB, Tompkins WA (1998) Mucosally transmitted feline immunodeficiency virus induces a CD8+ antiviral response that correlates with reduction of cell-associated virus. J Infect Dis 177:18-25
21. Burkhard MJ, Dean GA (2003) Transmission and immunopathogenesis of FIV in cats as a model for HIV. Curr HIV Res 1:15-29
22. Burkhard MJ, Mathiason CK, O'Halloran K, Hoover EA (2002) Kinetics of early FIV infection in cats exposed via the vaginal versus intravenous route. AIDS Res Hum Retrovir 18:217-226
23. Carpenter MA, O'Brien SJ (1995) Coadaptation and immunodeficiency virus: lessons from the Felidae. Curr Opin Genet Dev 5:739-745
24. Chen H, Wood C, Petito CK (2000) Comparisons of HIV-1 viral sequences in brain, choroid plexus and spleen: potential role of choroid plexus in the pathogenesis of HIV encephalitis. J Neurovirology 6:498-506
25. 1HMRS studies in a feline model of human disease. J Neuroimmunol 147:16-20
26. Cysique LA, Brew BJ, Halman M, Catalan J, Sacktor N, Price RW, Brown S, Atkinson JH, Clifford DB, Simpson D, Torres G, Hall C, Power C, Marder K, McArthur JC, Symonds W, Romero C (2005) Indetectable cerebrospinal fluid HIV RNA and beta-2 microglobulin do not indicate inactive AIDS dementia complex in highly active antiretroviral therapy-treated patients. J Acquir Immune Defic Syndr 39:426-429
27. D'Cruz OJ, Waurzyniak B, Uckun FM (2004) Antiretroviral spermicide WHI-07 prevents vaginal and rectal transmission of feline immunodeficiency virus in domestic cats. Antimicrob Agents Chemother 48:1082-1088
28. Danave IR, Tiffany Castiglioni E, Zenger E, Barhoumi R, Burghardt RC, Collisson EW (1994) Feline immunodeficiency virus decreases cell-cell communication and mitochondrial membrane potential. J Virol 68:6745-6750
29. de Parseval A, Chatterji U, Sun P, Elder JH (2004) Feline immunodeficiency virus targets activated CD4+ T cells by using CD134 as a binding receptor. Proc Natl Acad Sci USA 101:13044-13049
30. de Ronde A, Stam JG, Boers P, Langedijk H, Meloen R, Hesselink W, Keldermans LC, van Vliet A, Verschoor EJ, Horzinek MC (1994) Antibody response in cats to the envelope proteins of feline immunodeficiency virus: identification of an immunodominant neutralization domain. Virology 198:257-264
31. de Rozieres S, Swan CH, Sheeter DA, Clingerman KJ, Lin YC, Huitron-Resendiz S, Henriksen S, Torbett BE, Elder JH (2004) Assessment of FIV-C infection of cats as a function of treatment with the protease inhibitor, TL-3. Retrovirology 1:38
32. Del Mauro D, Matteucci D, Giannecchini S, Maggi F, Pistello M, Bendinelli M (1998) Autologous and heterologous neutralization analyses of primary feline immunodeficiency virus isolates. J Virol 72:2199-2207
33. Dou H, Birusingh K, Faraci J, Gorantla S, Poluektova LY, Maggirwar SB, Dewhurst S, Gelbard HA, Gendelman HE (2003) Neuro-protective activities of sodium valproate in a murine model of human immunodeficiency virus-1 encephalitis. J Neurosci 23:9162-9170
34. Dow S, Poss M, Hoover E (1990) Feline immunodeficiency virus: a neurotropic lentiviais. J AIDS 3:658-668
35. Dow SW, Dreitz MJ, Hoover EA (1992) Feline immunodeficiency viras neurotropism: evidence that astrocytes and microglia are the primary target cells, Vet Immunol Immunopathol 35:23-35
36. Dow SW, Mathiason CK, Hoover EA (1999) In vivo monocyte tropism of pathogenic feline immunodeficiency viruses. J Virol 73:6852-6861
37. Egberink H, Borst M, Niphuis H, Balzarini J, Neu H, Schellekens H, De Clercq E, Horzinek M, Koolen M (1990) Suppression of feline immunodeficiency virus infection in vivo by 9-(2-phosphonomethoxyethyl)adenine. Proc Natl Acad Sci USA 87:3087-3091
38. Egberink HF, De Clercq E, van Vliet AL, Balzarini J, Bridger GJ, Henson G, Horzinek MC, Schols D (1999) Bicyclams, selective antagonists of the human chemokine receptor CXCR4, potently inhibit feline immunodeficiency virus replication, J Virol 73:6346-6352
39. Elder JH, Phillips TR (1993) Molecular properties of feline immunodeficiency virus (FIV). Infect Agents Dis 2:361-374
40. Ellis RJ, Gamst AC, Capparelli E, Spector SA, Hsia K, Wolfson T, Abramson I, Grant I, McCutchan JA (2000) Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources. Neurology 54:927-936
41. English R, Johnson C, Gebhard DH, Tompkins MB (1993) In vivo lymphocyte tropism of feline immunodeficiency virus. J Virol 67:5175-5186
42. English RV, Nelson P, Johnson CM, Nasisse M, Tompkins WA, Tompkins MB (1994) Development of clinical disease in cats experimentally infected with feline immunodeficiency virus, J Infect Dis 170:543-552
43. Epstein LG, Gelbard HA (1999) HIV-1-induced neuronal injury in the developing brain. J Leukoc Biol 65:453-457
44. Falangola MF, Hanly A, Galvao-Castro B, Petito CK (1995) HIV infection of human choroid plexus: a possible mechanism of viral entry into the CNS. J Neuropathol Exp Sci 54:497-503
45. Fine SM, Angel RA, Perry SW, Epstein LG, Rothstein JD, Dewhurst S, Gelbard HA (1996) Tumor necrosis factor alpha inhibits glutamate uptake by primary human astrocytes. Implications for pathogenesis of HIV-1 dementia. J Biol Chem 271:15303-15306
46. Fischer-Smith T, Croul S, Sverstiuk AE, Capini C, L'Heureux D, Regulier EG, Richardson MW, Amini S, Morgello S, Khalili K., Rappaport J (2001) CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection. J Neurovirology 7:528-541
47. Garg H, Fuller FJ, Tompkins WA (2004) Mechanism of feline immunodeficiency virus envelope glycoprotein-mediated fusion. Virology 321:274-286
48. Gavrilin MA, Mathes LE, Podell M (2002) Methamphetamine enhances cell-associated feline immunodeficiency viras replication in astrocytes. J Neurovirology 8:240-249
49. Gebhard DH, Dow JL, Childers TA, Alvelo JI, Tompkins MB, Tompkins WA (1999) Progressive expansion of an L-selectin-negative CDS cell with anti-feline immunodeficiency virus (FIV) suppressor function in the circulation of FIV-infected cats. J Infect Dis 180:1503-1513
50. Gemignani A, Paudice P, Pittaluga A, Raiteri M (2000) The HIV-1 coat protein gp120 and some of its fragments potently activate native cerebral NMDA receptors mediating neuropeptide release. Eur J Neurosci 12:2839-2846
51. Gendelman HE, Lipton SA, Epstein LG, Swindells S (2005) The Neurology of AIDS, 2nd edn.: Oxford University Press
52. Giulian D, Vaca K, Noonan CA (1990) Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science 250:1593-1596
53. Gonzalez-Scarano F, Martin-Garcia J (2005) The neuropathogenesis of AIDS. Nat Rev Immunol 5:69-81
54. Gorry PR, Bristol G, Zack JA, Ritola K, Swanstrom R, Birch CJ, Bell JE, Bannert N, Crawford K, Wang H, Schols D, De Clercq E, Kunstman K, Wolinsky SM, Gabuzda D (2001) Macrophage tropism of human immunodeficiency viras type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity. J Virol 75:10073-10089
55. Gruol DL, Yu N, Parsons KL, Billaud JN, Elder JH, Phillips TR (1998) Neurotoxic effects of feline immunodeficiency virus, FIV-PPR. J Neurovirology 4:415-425
56. Hartmann K, Donath A, Beer B, Egberink HF, Horzinek MC, Lutz H, Hoffmann-Fezer G, Thum 1, Thefeld S (1992) Use of two virustatica (AZT, PMEA) in the treatment of FIV and of FeLV seropositive cats with clinical symptoms. Vet Immunol Immuno-pathol 35:167-175
57. Haughey NJ, Holden CP, Nath A, Geiger JD (1999) Involvement of inositol 1,4,5-trisphosphate-regulated stores of intracellular calcium in calcium dysregulation and neuron cell death caused by HIV-1 protein tat. J Neurochem 73:1363-1374
58. Haughey NJ, Nath A, Mattson MP, Slevin JT, Geiger JD (2001) HIV-1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity, J Neurochem 78:457-467
59. Hayes KA, Wilkinson JG, Frick R, Francke S, Mathes LE (1995) Early suppression of viremia by ZDV does not alter the spread of feline immunodeficiency virus infection in cats. J Acquir Immune Defic Syndr Hum Retrovirol 9:114-122
60. Hegg CC, Thayer SA (1999) Monocytic cells secrete factors that evoke excitatory synaptic activity in rat hippocampal cultures. Eur J Pharmacol 385:231-237
61. Hein A, Martin JP, Dorries R (2001) In vitro activation of feline immunodeficiency virus in ramified microglial cells from asymptomatically infected cats. J Virol 75:8090-8095
62. Hein A, Martin JP, Koehren F, Bingen A, Dorries R (2000) In vivo infection of ramified microglia from adult cat central nervous system by feline immunodeficiency virus. Virology 268:420-429
63. Hoffmann-Fezer G, Thurn J, Ackley C, Herbold M, Mysliwietz J, Thefeld S, Hartmann K, Kraft W (1992) Decline in CD4+ cell numbers in cats with naturally acquired feline immunodeficiency virus infection. J Virol 66:1484-1488
64. Hohdatsu T, Fujimori S, Maeki M, Suma N, Motokawa K, Okada S, Koyama H (1997) Virus neutralizing antibody titer to feline immunodeficiency virus isolates of subtypes A, B and D in experimentally or naturally infected cats. J Vet Med Sci 59:377-381
65. Hohdatsu T, Miyagawa N, Ohkubo M, Kida K, Koyama H (2000) Studies on feline CD8+ T cell non-cytolytic anti-feline immunodeficiency virus (FIV) activity. Arch Virol 145:2525-2538
66. Hohdatsu T, Sasagawa T, Yamazaki A, Motokawa K, Kusuhara H, Kaneshima T, Koyama H (2002) CD8+ T cells from feline immunodeficiency virus (FIV) infected cats suppress exogenous FIV replication of their peripheral blood mononuclear cells in vitro. Arch Virol 147:1517-1529
67. 2+ in human neurons and astrocytes. Neuroscience 91:1369-1378
68. Hosie MJ, Broere N, Hesselgesser J, Turner JD, Hoxie JA, Neil JC, Willett BJ (1998) Modulation of feline immunodeficiency virus infection by stromal cell-derived factor. J Virol 72:2097-2104
69. Huang C, Conlee D, Loop J, Champ D, Gill M, Chu HJ (2004) Efficacy and safety of a feline immunodeficiency viras vaccine. Anim Health Res Rev 5:295-300
70. Hudson LC, Bragg DC, Tompkins MB, Meeker RB (2005) Astrocytes and microglia differentially regulate trafficking of lymphocyte subsets across brain endothelial cells. Brain Res 1058:148-160
71. Hurtrel M, Ganiere J, Guelifi J, Chakrabarti L, Maire M, Gray F, Montagnier L, Hurtrel B (1992) Comparison of early and late feline immunodeficiency virus encephalopathies. AIDS 6:399-406
72. Jacobson S, Henricksen SJ, Prospero-Garcia O, Phillips TR, Elder JH, Young WG, Bloom FE, Fox HS (1997) Cortical neuronal cytoskeletal changes associated with FIV infection. Journal Neurovirology 3:283-289
73. Johnston JB, Power C (2002) Feline immunodeficiency virus xenoinfection: the role of chemokine receptors and envelope diversity. J Virol 76:3626-3636
74. Jones G, Power C (2006) Regulation of neural cell survival by HIV-1 infection. Neurobiol Dis 21:1-17
75. Jordan HL, Howard JG, Bucci JG, Butterworth JL, English R, Kennedy-Stoskopf S, Tompkins MB, Tompkins WA (1998) Horizontal transmission of feline immunodeficiency virus with semen from seropositive cats. J Reprod Immunol 41:341-357
76. Kanki PJ, McLane MF, King NW Jr, Letvin NL, Hunt RD, Sehgal P, Daniel MD, Desrosiers RC, Essex M (1985) Serologic identification and characterization of a macaque T-lymphotropic retrovirus closely related to HTLV-III. Science 228:1199-1201
77. Kawaguchi Y, Maeda K, Tohya Y, Furuya T, Miyazawa T, Horimoto T, Norimine J, Kai C, Mikami T (1992) Replicative difference in early-passage feline brain cells among feline immunodeficiency virus isolates. Arch Virol 125:347-354
78. Koenig S, Gendelman HE, Orenstein JM, Dal Canto MC, Pezeshkpour GH, Yungbluth M, Janotta F, Aksamit A, Martin MA, Fauci AS (1986) Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233:1089-1093
79. Koirala TR, Nakagaki K, Ishida T, Nonaka S, Morikawa S, Tabira T (2001) Decreased expression of MAP-2 and GAD in the brain of cats infected with feline immunodeficiency virus. Tohoku J Exp Med 195:141-151
80. Kolson DL (2002) Neuropathogenesis of central nervous system HIV-1 infection. Clin Lab Med 22:703-717
81. Kovacs EM, Baxter GD, Robinson WF (1999) Feline peripheral blood mononuclear cells express message for both CXC and CC type chemokine receptors, Arch Virol 144:273-285
82. Lane JH, Sasseville VG, Smith MO, Vogel P, Pauley DR, Heyes MP, Lackner AA (1996) Neuroinvasion by simian immunodeficiency virus coincides with increased numbers of perivascular macro-phages/microglia and intrathecal immune activation. J Neurovirology 2:423-432
83. Lerner DL, Elder JH (2000) Expanded host cell tropism and cytopathic properties of feline immunodeficiency virus strain PPR subsequent to passage through interleukin-2-independent T cells. J Virol 74:1854-1863
84. Levy JA (1993) Pathogenesis of human immunodeficiency virus infection. Microbiol Rev 57:183-289
85. Lipton S (1992) Models of neuronal injury in AIDS: another role for the NMDA receptor? TINS 15:75-80
86. Lipton S, Sucher N, Kaiser P, Dreyer E (1991) Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron 7:111-118
87. Liu P, Hudson LC, Tompkins MB, Vahlenkamp TW, Colby B, Rundle C, Meeker RB (2006a) Cerebrospinal fluid is an efficient route for establishing brain infection with feline immunodeficiency virus and transferring infectious virus to the periphery. J Neurovirology 12:294-306
88. Liu P, Hudson LC, Tompkins MB, Vahlenkamp TW, Meeker RB (2006b) Compartmentalization and evolution of feline immuno-deficiency virus between the central nervous system and periphery following intracerebroventricular or systemic inoculation. J Neurovirology 12:307-321
89. Livingstone WJ, Moore M, Innes D, Bell JE, Simmonds P (1996) Frequent infection of peripheral blood CDS-positive T-lymphocytes with HIV-1. Edinburgh Heterosexual Transmission Study Group. Lancet 348:649-654
90. Lo TK., Fallert CJ, Piser TM, Thayer SA (1992) HIV-1 envelope protein evokes intracellular calcium oscillations in rat hippocampal neurons. Brain Res 594:189-196
91. Lombardi S, Massi C, Tozzini F, Zaccaro L, Bazzichi A, Bandecchi P, La Rosa C, Bendinelli M, Garzelli C (1995) Epitope mapping of the V3 domain of feline immunodeficiency virus envelope glycoprotein by monoclonal antibodies. J Gen Virol 76 (Pt 8): 1893-1899
92. Macchi S, Maggi F, Di Iorio C, Poli A, Bendinelli M, Pistello M (1998) Detection of feline immunodeficiency proviral sequences in lymphoid tissues and the central nervous system by in situ gene amplification. J Virol Methods 73:109-119
93. Masliah E, Heaton RK, Marcotte TD, Ellis RJ, Wiley CA, Mallory M, Achim CL, McCutchan JA, Nelson JA, Atkinson JH, Grant 1 (1997) Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center. Ann Neurol 42:963-972
94. McArthur JC, Brew BJ, Nath A (2005) Neurological complications of HIV infection. Lancet Neurol 4:543-555
95. Meeker R, English R, Tompkins M (1996) Enhanced excitotoxicity in primary feline neural cultures exposed to feline immunodeficiency virus (FIV). J Neuro-AIDS 1:1-27
96. Meeker RB, Azuma Y, Bragg DC, English RV, Tompkins M (1999a) Microglial proliferation in cortical neural cultures exposed to feline immunodeficiency virus, J Neuroimmunol 101:15-26
97. Meeker RB, Boles JC, Robertson KR, Hall CD (2005) Cerebrospinal fluid from human immunodeficiency virus-infected individuals facilitates neurotoxicity by suppressing intracellular calcium recovery. J Neurovirology 11:144-156
98. Meeker RB, Robertson K, Barry T, Hall C (1999b) Neurotoxicity of CSF from HIV-infected humans. J Neurovirology 5:507-518
99. Meeker RB, Thiede BA, Hall C, English R, Tompkins M (1997) Cortical cell loss in asymptomatic cats experimentally infected with feline immunodeficiency virus. AIDS Res Hum Retrovir 13:1131-1140
100. Mitchell TW, Buckmaster PS, Hoover EA, Whalen LR, Dudek FE (1999) Neuron loss and axon reorganization in the dentate gyrus of cats infected with the feline immunodeficiency virus. J Comp Neurol 411:563-577
101. Nagra RM, Masliah E, Wiley CA (1993) Synaptic and dendritic pathology in murine retroviral encephalitis. Exp Neurol 124:283-288
102. Nakagaki K, Nakagaki K, Takahashi K, Schols D, De Clercq E, Tabira T (2001) CXCR4 is the primary receptor for feline immunodeficiency virus in astrocytes, J Neurovirology 7:487-492
103. Neuenburg JK, Brodt HR, Herndier BG, Bickel M, Bacchetti P, Price RW, Grant RM, Schlote W (2002) HIV-related neuropathology, 1985 to 1999: rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 31:171-177
104. Novotney C, English R, Housman J, Davidson M, Nasisse M, Jeng CR, Davis W, Tompkins M (1990) Lymphocyte population changes in cats naturally infected with feline immunodeficiency virus. AIDS 4:1213-1218
105. O'Neil LL, Burkhard MJ, Hoover EA (1996) Frequent perinatal transmission of feline immunodeficiency virus by chronically infected cats. J Virol 70:2894-2901
106. Obert LA, Hoover EA (2002) Early pathogenesis of transmucosal feline immunodeficiency virus infection. J Virol 76:6311-6322
107. Olmsted R, Hirsch V, Purcell R, Johnson P (1989) Nucleotide sequence analysis of feline immunodeficiency virus:genome organization and relationship to other lentiviruses. Proc Natl Acad Sci 86:8088-8092
108. Osborne R, Rigby M, Siebelink K, Neil JC, Jarrett O (1994) Virus neutralization reveals antigenic variation among feline immunodeficiency virus isolates. J Gen Virol 75 (Pt 12):3641-3645
109. Pedersen NC, Ho EW, Brown ML, Yamamoto JK (1987) Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science 235:790-793
110. Perry SW, Norman JP, Gelbard HA (2005) Adjunctive therapies for HIV-1 associated neurologic disease. Neurotox Res 8:161-166
111. Persidsky Y, Stins M, Way D, Witte MH, Weinand M, Kim KS, Bock P, Gendelman HE, Fiala M (1997) A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis. J Immunol 158:3499-3510
112. Petito CK (2004) Human immunodeficiency virus type 1 compartmentalization in the central nervous system. J Neurovirology 10 Suppl 1:21-24
113. Petito CK, Chen H, Mastri AR, Torres-Munoz J, Roberts B, Wood C (1999) HIV infection of choroid plexus in AIDS and asymptomatic HIV-infected patients suggests that the choroid plexus may be a reservoir of productive infection. J Neurovirology 5:670-677
114. Phillips T, Prospero-Garcia O, Puaoi D, Lerner D, Fox H, Olmsted R, Bloom F, Heriksen S, Elder J (1994) Neurological abnormalities associated with feline immunodeficiency virus infection. J Gen Virol 75:979-987
115. Phillips TR, Prospero-Garcia O, Wheeler DW, Wagaman P, Lerner DL, Fox HS, Whalen LR, Bloom FE, Elder JH, Henricksen SJ (1996) Neurologic dysfunctions caused by a molecular clone of feline immunodeficiency virus, FIV-PPR. J Neurovirology 2:388-396
116. Phipps AJ, Hayes KA, Buck WR, Podell M, Mathes LE (2000) Neurophysiologic and immunologic abnormalities associated with feline immunodeficiency virus molecular clone FIV-PPR DNA inoculation. J Acquir Immune Defic Syndr 23:8-16
117. Pistello M, Menzo S, Giorgi M, Da Prato L, Cammarota G, Clementi M, Bendinelli M (1994) Competitive polymerase chain reaction for quantitating feline immunodeficiency virus load in infected cat tissues. Mol Cell Probes 8:229-234
118. Podell M, Hayes K, Oglesbee M, Mathes L (1997) Progressive encephalopathy associated with CD4/CD8 inversion in adult FIV-infected cats. J Acquir Immune Defic Syndr Hum Retrovirol 15:332-340
119. Podell M, Maruyama K, Smith M, Hayes KA, Buck WR, Ruehlmann DS, Mathes LE (1999) Frontal lobe neuronal injury correlates to altered function in FIV-infected cats. J Acquir Immune Defic Syndr 22:10-18
120. Podell M, Oglesbee M, Mathes L, Krakowka S, Olmstead R, Lafrado L (1993) AIDS-associated encephalopathy with experimental feline immunodeficiency virus Infection, J AIDS 6:758-771
121. Poli A, Abramo F, Di Iorio C, Cantile C, Carli MA, Pollera C, Vago L, Tosoni A, Costanzi G (1997) Neuropathology in cats experimentally infected with feline immunodeficiency virus: a morphological, immunocytochemical and morphometric study. J Neurovirology 3:361-368
122. Poli A, Pistello M, Carli MA, Abramo F, Mancuso G, Nicoletti E, Bendinelli M (1999) Tumor necrosis factor-alpha and virus expression in the central nervous system of cats infected with feline immunodeficiency virus, J Neurovirology 5:465-473
123. Potter SJ, Dwyer DE, Saksena NK. (2003) Differential cellular distribution of HIV-1 drug resistance in vivo: evidence for infection of CD8+ T cells during HAART. Virology 305:339-352
124. Power C, Buist R, Johnston JB, Del Bigio MR, Ni W, Dawood MR, Peeling J (1998) Neurovirulence in feline immunodeficiency virus-infected neonatal cats is viral strain specific and dependent on systemic immune suppression, J Virol 72:9109-9115
125. Power C, Moench T, Peeling J, Kong PA, Langelier T (1997) Feline immunodeficiency virus causes increased glutamate levels and neuronal loss in brain. Neuroscience 77:1175-1185
126. Prospero-Garcia O, Herold N, Phillips T, Elder J, Bloom F, Henriksen S (1994) Sleep patterns are disturbed in cats infected with feline immunodeficiency virus. Proc Natl Acad Sci 91:12947-12951
127. Pu R, Coleman J, Omori M, Arai M, Hohdatsu T, Huang C, Tanabe T, Yamamoto JK (2001) Dual-subtype FIV vaccine protects cats against in vivo swarms of both homologous and heterologous subtype FIV isolates. AIDS 15:1225-1237
128. Pulliam L, Herndier BG, Tang NM, McGrath MS (1991) Human immunodeficiency virus-infected macrophages produce soluble factors that cause histological and neurochemical alterations in cultured human brains. J Clin Invest 87:503-512
129. Richardson J, Fossati I, Moraillon A, Castelot S, Sonigo P, Pancino G (1996) Neutralization sensitivity and accessibility of continuous B cell epitopes of the feline immunodeficiency virus envelope. J Gen Virol 77 (Pt 4):759-771
130. Richardson J, Pancino G, Merat R, Leste-Lasserre T, Moraillon A, Schneider-Mergener J, Alizon M, Sonigo P, Heveker N (1999) Shared usage of the chemokine receptor CXCR4 by primary and laboratory-adapted strains of feline immunodeficiency virus. J Virol 73:3661-3671
131. Ryan G, Grimes T, Brankin B, Mabruk MJ, Hosie MJ, Jarrett O, Callanan JJ (2005) Neuropathology associated with feline immunodeficiency virus infection highlights prominent lymphocyte trafficking through both the blood-brain and blood-choroid plexus barriers. J Neurovirology 11:337-345
132. Ryan G, Klein D, Knapp E, Hosie MJ, Grimes T, Mabruk MJ, Jarrett O, Callanan JJ (2003) Dynamics of viral and proviral loads of feline immunodeficiency virus within the feline central nervous system during the acute phase following intravenous infection. J Virol 77:7477-7485
133. Sacktor N, McDermott MP, Marder K, Schifitto G, Selnes OA, McArthur JC, Stern Y, Albert S, Palumbo D, Kieburtz K, De Marcaida JA, Cohen B, Epstein L (2002) HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirology 8:136-142
134. 2+ that require function of an N-methyl-D-aspartate receptor polyamine-sensitive site. Brain Res 995:39-45
135. Shimojima M, Miyazawa T, Ikeda Y, McMonagle EL, Haining H, Akashi H, Takeuchi Y, Hosie MJ, Willett BJ (2004) Use of CD134 as a primary receptor by the feline immunodeficiency virus. Science 303:1192-1195
136. Siebelink KH, Bosch ML, Rimmelzwaan GF, Meloen RH, Osterhaus AD (1995) Two different mutations in the envelope protein of feline immunodeficiency virus allow the virus to escape from neutralization by feline serum antibodies. Vet Immunol Immunopathol 46:51-59
137. Silvotti L, Corradi A, Brandi G, Cabassi A, Bendinelli M, Magnan M, Piedimonte G (1997) FIV induced encephalopathy: early brain lesions in the absence of viral replication in monocyte/macrophages. A pathogenetic model. Vet Immunol Immunopathol 55:263-271
138. Steffan AM, Lafon ME, Gendrault JL, Koehren F, De Monte M, Royer C, Kim A, Gut JP (1994) Feline immunodeficiency virus can productively infect cultured endothelial cells from cat brain microvessels. J Gen Virol 75:3647-3653
139. Steffen BJ, Breier G, Butcher EC, Schulz M, Engelhardt B (1996) ICAM-1, VCAM-1, and MAdCAM-1 are expressed on choroid plexus epithelium but not endothelium and mediate binding of lymphocytes in vitro. Am J Pathol 148:1819-1838
140. Steigerwald ES, Sarter M, March P, Podell M (1999) Effects of feline immunodeficiency virus on cognition and behavioral function in cats. J Acquir Immune Defic Syndr Hum Retrovirol 20:411-419
141. Strain MC, Letendre S, Pillai SK, Russell T, Ignacio CC, Gunthard HF, Good B, Smith DM, Wolinksy SM, Furtado M, Marquie-Beck J, Durelle J, Grant I, Richman DD, Marcotte T, McCutchan JA, Ellis RJ, Wong JK (2005) Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy. J Virol 79:1772-1788
142. Talbott RL, Sparger EE, Lovelace KM, Fitch WM, Pedersen NC, Luciw PA, Elder JH (1989) Nucleotide sequence and genomic organization of feline immunodeficiency virus, Proc Natl Acad Sci USA 86:5743-5747
143. Toggas SM, Masliah E, Mucke L (1996) Prevention of HIV-1 gp120-induced neuronal damage in the central nervous system of transgenic mice by the NMDA receptor antagonist memantine. Brain Res 706:303-307
144. Tompkins MB, Nelson PD, English RV, Novotney C (1991) Early events in the immunopathogenesis of feline retrovirus infections. JAVMA 199:1311-1315
145. Torten M, Franchini M, Barlough JE, George JW, Mozes E, Lutz H, Pedersen NC (1991) Progressive immune dysfunction in cats experimentally infected with feline immunodeficiency virus. J Virol 65:2225-2230
146. Turchan J, Sacktor N, Wojna V, Conant K, Nath A (2003) Neuro-protective therapy for HIV dementia. Curr HIV Res 1:373-383
147. Tymianski M (1996) Cytosolic calcium concentrations and cell death in vitro. Adv Neurol 71:85-105
148. Tymianski M, Charlton MP, Carlen PL, Tator CH (1993) Source specificity of early calcium neurotoxicity in cultured embryonic spinal neurons. J Neurosci 13:2085-2104
149. Uhl EW, Heaton-Jones TG, Pu R, Yamamoto JK (2002) FIV vaccine development and its importance to veterinary and human medicine: a review FIV vaccine 2002 update and review. Vet Immunol Immunopathol 90:113-132
150. Vahlenkamp TW, Tompkins MB, Tompkins WA (2005) The role of CD4+CD25+ regulatory T cells in viral infections. Vet Immunol Immunopathol 108:219-225
151. Wasmoen T, Armiger-Luhman S, Egan C, Hall V, Chu HJ, Chavez L, Acree W (1992) Transmission of feline immunodeficiency virus from infected queens to kittens. Vet Immunol Immunopathol 35:83-93
152. Wiley C, Masliah E, Morey M, Lemere C, DeTeresa R, Grafe M, Hansen L, Terry R (1991) Neocortical damage during HIV infection. Ann Neurol 29:651-657
153. Willett BJ, Cannon CA, Hosie MJ (2002) Upregulation of surface feline CXCR4 expression following ectopic expression of CCR5: implications for studies of the cell tropism of feline immunodeficiency virus. J Virol 76:9242-9252
154. Willett BJ, Hosie MJ, Callanan JJ, Neil JC, Jarrett O (1993) Infection with feline immunodeficiency virus is followed by the rapid expansion of a CD8+ lymphocyte subset. Immunology 78:1-6
155. Willett BJ, Picard L, Hosie MJ, Turner JD, Adema K, Clapham PR (1997) Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses. J Virol 71:6407-6415
156. Williams KC, Corey S, Westmoreland SV, Pauley D, Knight H, deBakker C, Alvarez X, Lackner AA (2001) Perivascular macro-phages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS. J Exp Med 193:905-915
157. Xiong H, Zheng J, Thylin M, Gendelman HE (1999) Unraveling the mechanisms of neurotoxicity in HIV type 1-associated dementia: inhibition of neuronal
158. Yeh MW, Kaul M, Zheng J, Nottet HS, Thylin M, Gendelman HE, Lipton SA (2000) Cytokine-stimulated, but not HIV-infected, human monocyte-derived macrophages produce neurotoxic levels of L-cysteine. J Immunol 164:4265-4270
159. Yu N, Billaud JN, Phillips TR (1998) Effects of feline immunodeficiency virus on astrocyte glutamate uptake: implications for lentivirus-induced central nervous system diseases. Proc Natl Acad Sci USA 95:2624-2629
160. Zenger E, Collisson EW, Barhoumi R, Burghardt RC, Danave IR, Tiffany-Castiglioni E (1995) Laser cytometric analysis of FIV-induced injury in astroglia. Glia 13:92-100
161. Zenger E, Tiffany-Castiglioni E, Collisson EW (1997) Cellular mechanisms of feline immunodeficiency virus (FIV)-induced neuropathogenesis. Front Biosci 2:d527-d537
162. Zheng J, Ghorpade A, Niemann D, Cotter RL, Thylin MR, Epstein L, Swartz JM, Shepard RB, Liu X, Nukuna A, Gendelman HE (1999a) Lymphotropic virions affect chemokine receptor-mediated neural signaling and apoptosis: implications for human immunodeficiency virus type 1-associated dementia. J Virol 73:8256-8267
163. Zheng J, Thylin MR, Cotter RL, Lopez AL, Ghorpade A, Persidsky Y, Xiong H, Leisman GB, Che MH, Gendelman HE (2001) HIV-1 infected and immune competent mononuclear phagocytes induce quantitative alterations in neuronal dendritic arbor: relevance for HIV-1-associated dementia. Neurotox Res 3:443-459
164. Zheng J, Thylin MR, Ghoipade A, Xiong H, Persidsky Y, Cotter R, Niemann D, Che M, Zeng YC, Gelbard HA, Shepard RB, Swartz JM, Gendelman HE (1999b) Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-1-associated dementia. J Neuroimmunol 98:185-200